Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Albaha Barqawi

Concepts (161)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms
18
2021
1010
2.710
Why?
Cryotherapy
4
2021
21
2.260
Why?
Prostate
3
2020
150
0.920
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2021
165
0.840
Why?
Imaging, Three-Dimensional
3
2020
548
0.760
Why?
Neoplasm Recurrence, Local
1
2020
767
0.580
Why?
Prostate-Specific Antigen
8
2020
167
0.530
Why?
Lower Urinary Tract Symptoms
1
2013
43
0.500
Why?
Symptom Assessment
1
2013
126
0.480
Why?
Ultrasound, High-Intensity Focused, Transrectal
1
2011
3
0.460
Why?
Antineoplastic Agents, Hormonal
3
2005
145
0.380
Why?
Testosterone
3
2013
305
0.370
Why?
Ultrasonography, Interventional
3
2020
133
0.370
Why?
Androgen Antagonists
3
2006
81
0.340
Why?
Prostatic Hyperplasia
2
2005
31
0.340
Why?
Mass Screening
2
2005
1038
0.340
Why?
Erectile Dysfunction
1
2005
31
0.300
Why?
Hormone Replacement Therapy
1
2005
78
0.290
Why?
Self Medication
1
2004
13
0.280
Why?
Prazosin
1
2004
38
0.280
Why?
Flutamide
1
2003
5
0.280
Why?
Plant Preparations
1
2004
24
0.270
Why?
Phytotherapy
1
2004
69
0.270
Why?
Cryptorchidism
1
2003
11
0.270
Why?
Palpation
1
2003
16
0.270
Why?
Anticarcinogenic Agents
1
2004
76
0.260
Why?
Complementary Therapies
1
2004
79
0.260
Why?
Testis
1
2003
130
0.250
Why?
Vitamins
1
2004
141
0.250
Why?
Male
21
2021
60721
0.230
Why?
Combined Modality Therapy
2
2021
1240
0.230
Why?
Adenocarcinoma
2
2007
800
0.220
Why?
Neoplasm Staging
1
2004
1220
0.210
Why?
Kallikreins
1
2020
40
0.210
Why?
Image-Guided Biopsy
1
2020
35
0.210
Why?
Urination Disorders
2
2013
14
0.210
Why?
Dietary Supplements
1
2004
430
0.210
Why?
Middle Aged
11
2021
28678
0.200
Why?
Health Status
1
2005
769
0.200
Why?
Aged
10
2020
20026
0.200
Why?
Laparoscopy
1
2003
383
0.190
Why?
African Americans
1
2005
1096
0.190
Why?
Prospective Studies
3
2021
6168
0.190
Why?
Biopsy, Needle
2
2008
196
0.180
Why?
Humans
22
2021
112255
0.160
Why?
Pilot Projects
1
2021
1406
0.160
Why?
Survival Rate
1
2021
1851
0.160
Why?
Prostatectomy
2
2007
108
0.140
Why?
Andropause
1
2013
9
0.140
Why?
Nocturia
1
2013
7
0.140
Why?
Urology
1
2013
43
0.130
Why?
Dexamethasone
2
2006
318
0.130
Why?
Case-Control Studies
1
2021
3353
0.130
Why?
Prognosis
1
2021
3532
0.120
Why?
Biopsy
2
2007
1065
0.120
Why?
Aged, 80 and over
5
2007
6779
0.110
Why?
Follow-Up Studies
1
2021
4888
0.110
Why?
Retrospective Studies
4
2020
11118
0.110
Why?
Quality of Life
2
2020
2089
0.110
Why?
Image Interpretation, Computer-Assisted
2
2008
252
0.100
Why?
Societies, Medical
1
2013
764
0.100
Why?
Treatment Outcome
3
2020
8944
0.090
Why?
Models, Anatomic
1
2008
102
0.090
Why?
Risk Factors
3
2005
8979
0.080
Why?
Patient Selection
1
2011
692
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2006
1388
0.080
Why?
Cryosurgery
1
2007
57
0.080
Why?
Carboplatin
1
2006
138
0.080
Why?
Myocardial Infarction
1
2013
1111
0.080
Why?
Adult
5
2007
31793
0.080
Why?
Minimally Invasive Surgical Procedures
1
2007
141
0.080
Why?
Stroke
1
2013
916
0.080
Why?
Orchiectomy
1
2005
57
0.070
Why?
Severity of Illness Index
1
2013
2817
0.070
Why?
Doxazosin
1
2004
1
0.070
Why?
Penile Erection
1
2004
8
0.070
Why?
Finasteride
1
2004
10
0.070
Why?
Age Distribution
1
2005
402
0.070
Why?
Adrenergic alpha-Antagonists
1
2004
42
0.070
Why?
Selenium
1
2004
35
0.070
Why?
Prostaglandin-Endoperoxide Synthases
1
2004
85
0.070
Why?
Inguinal Canal
1
2003
5
0.070
Why?
Seminal Vesicles
1
2003
12
0.070
Why?
Peritoneal Cavity
1
2003
30
0.070
Why?
Vas Deferens
1
2003
20
0.070
Why?
Early Diagnosis
1
2005
246
0.070
Why?
Seminoma
1
2003
17
0.070
Why?
Gastroschisis
1
2003
22
0.070
Why?
Anus, Imperforate
1
2003
21
0.070
Why?
Guidelines as Topic
1
2005
285
0.070
Why?
Patient Care Planning
1
2004
165
0.060
Why?
Hypospadias
1
2003
22
0.060
Why?
Radiation Injuries
1
2004
127
0.060
Why?
Cyclooxygenase 2
1
2004
196
0.060
Why?
Cyclophosphamide
1
2003
236
0.060
Why?
Brachytherapy
1
2003
96
0.060
Why?
United States
2
2013
12170
0.060
Why?
Chromosome Aberrations
1
2003
145
0.060
Why?
Drug Utilization
1
2004
182
0.060
Why?
Vitamin D
1
2006
326
0.060
Why?
Carcinoma
1
2004
212
0.060
Why?
Surveys and Questionnaires
2
2005
4550
0.060
Why?
Isoenzymes
1
2004
367
0.060
Why?
Forecasting
1
2005
399
0.060
Why?
Urinary Bladder, Neurogenic
1
2002
23
0.060
Why?
Testicular Neoplasms
1
2003
91
0.060
Why?
Drug Resistance, Neoplasm
2
2004
679
0.060
Why?
Ultrasonography
1
2007
764
0.060
Why?
Health Surveys
1
2004
497
0.060
Why?
Sulfonamides
1
2004
439
0.050
Why?
Comorbidity
1
2005
1598
0.050
Why?
Family
1
2004
569
0.050
Why?
Antioxidants
1
2004
569
0.050
Why?
Disease Progression
2
2004
2474
0.050
Why?
Socioeconomic Factors
1
2004
1206
0.050
Why?
Randomized Controlled Trials as Topic
1
2004
1130
0.050
Why?
Research Design
1
2004
901
0.040
Why?
Antibodies, Monoclonal
1
2004
1294
0.040
Why?
Membrane Proteins
1
2004
1091
0.040
Why?
Smoking
1
2005
1627
0.040
Why?
Oxidative Stress
1
2004
1237
0.040
Why?
Colorado
1
2004
4552
0.030
Why?
Antineoplastic Agents
1
2004
2048
0.030
Why?
Mortality
1
2013
327
0.030
Why?
Coronary Angiography
1
2013
331
0.030
Why?
Risk
1
2013
944
0.030
Why?
Infant
1
2003
8024
0.030
Why?
Subtraction Technique
1
2008
29
0.020
Why?
Child, Preschool
1
2003
9655
0.020
Why?
Rectum
1
2008
151
0.020
Why?
Child
2
2003
17358
0.020
Why?
Coronary Artery Disease
1
2013
693
0.020
Why?
Medical History Taking
1
2007
127
0.020
Why?
Syndrome
1
2007
342
0.020
Why?
Pedigree
1
2007
518
0.020
Why?
Gynecomastia
1
2005
6
0.020
Why?
Hot Flashes
1
2005
71
0.020
Why?
Veterans
1
2013
874
0.020
Why?
Muscular Diseases
1
2005
102
0.020
Why?
Sexual Dysfunction, Physiological
1
2005
64
0.020
Why?
Adolescent
1
2003
18579
0.020
Why?
Trastuzumab
1
2004
95
0.020
Why?
Computer Simulation
1
2008
943
0.020
Why?
Anemia
1
2005
164
0.020
Why?
Infusions, Intravenous
1
2004
412
0.020
Why?
Cohort Studies
1
2013
4937
0.020
Why?
In Situ Hybridization, Fluorescence
1
2004
330
0.020
Why?
Gastrointestinal Diseases
1
2005
205
0.020
Why?
Osteoporosis
1
2005
194
0.020
Why?
Bladder Exstrophy
1
2002
17
0.020
Why?
Cystostomy
1
2002
9
0.020
Why?
Spinal Dysraphism
1
2002
32
0.010
Why?
Urethra
1
2002
48
0.010
Why?
Receptor, ErbB-2
1
2004
321
0.010
Why?
Transplantation, Autologous
1
2002
195
0.010
Why?
Neural Tube Defects
1
2002
67
0.010
Why?
Animals
1
2004
35194
0.010
Why?
Body Composition
1
2005
739
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2004
623
0.010
Why?
Immunohistochemistry
1
2004
1828
0.010
Why?
Mental Disorders
1
2005
929
0.010
Why?
Barqawi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)